{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:07:24Z","timestamp":1786993644567,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ7018"],"award-info":[{"award-number":["2024JJ7018"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.leukres.2024.107593","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T14:40:16Z","timestamp":1726584016000},"page":"107593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Roles of noncoding RNAs in multiple myeloma"],"prefix":"10.1016","volume":"146","author":[{"given":"Ming","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Langui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2024.107593_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin Oncol."},{"key":"10.1016\/j.leukres.2024.107593_bib2","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1159\/000520504","article-title":"Current treatment approaches to newly diagnosed multiple myeloma","volume":"44","author":"Ghandili","year":"2021","journal-title":"Oncol. Res Treat."},{"key":"10.1016\/j.leukres.2024.107593_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/EBC20200032","article-title":"Non-coding RNA in cancer","volume":"65","author":"Yan","year":"2021","journal-title":"Essays Biochem"},{"key":"10.1016\/j.leukres.2024.107593_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2020.04.023","article-title":"Non-coding RNA in bladder cancer","volume":"485","author":"Li","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.leukres.2024.107593_bib5","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.047662","article-title":"miRNA interplay: mechanisms and consequences in cancer","volume":"14","author":"Hill","year":"2021","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.leukres.2024.107593_bib6","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","article-title":"Integrated lncRNA function upon genomic and epigenomic regulation","volume":"82","author":"Herman","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.leukres.2024.107593_bib7","article-title":"tRNA-derived RNAs: biogenesis and roles in translational control","volume":"14","author":"Akiyama","year":"2023","journal-title":"Wiley Inter. Rev. RNA"},{"key":"10.1016\/j.leukres.2024.107593_bib8","doi-asserted-by":"crossref","first-page":"20598","DOI":"10.18632\/aging.203450","article-title":"Knockdown of hsa_circ_0091994 constrains gastric cancer progression by suppressing the miR-324-5p\/HMGA1 axis","volume":"13","author":"Xie","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.leukres.2024.107593_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174178","article-title":"siRNA: mechanism of action, challenges, and therapeutic approaches","volume":"905","author":"Alshaer","year":"2021","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.leukres.2024.107593_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246249","article-title":"Deciphering miRNAs' Action through miRNA Editing","volume":"20","author":"Correia de Sousa","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.leukres.2024.107593_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051723","article-title":"Regulatory mechanism of MicroRNA expression in cancer","volume":"21","author":"Ali Syeda","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.leukres.2024.107593_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2015.10.003","article-title":"Exploring miRNA based approaches in cancer diagnostics and therapeutics","volume":"98","author":"Mishra","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.leukres.2024.107593_bib13","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41417-020-00291-4","article-title":"Roles of miRNA dysregulation in the pathogenesis of multiple myeloma","volume":"28","author":"Chen","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.leukres.2024.107593_bib14","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.2174\/0929867328666210504104419","article-title":"MicroRNA in multiple myeloma - a role in pathogenesis and prognostic significance","volume":"28","author":"Pu\u0142a","year":"2021","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.leukres.2024.107593_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231202391","article-title":"miRNAs and multiple myeloma: focus on the pathogenesis, prognosis, and drug resistance","volume":"22","author":"Tavakoli Pirzaman","year":"2023","journal-title":"Technol. Cancer Res Treat."},{"key":"10.1016\/j.leukres.2024.107593_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.572689","article-title":"Exosomal miRNA-16-5p derived from M1 macrophages enhances t cell-dependent immune response by regulating PD-L1 in gastric cancer","volume":"8","author":"Li","year":"2020","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.leukres.2024.107593_bib17","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.2147\/OTT.S153888","article-title":"MiRNA-16 inhibited oral squamous carcinoma tumor growth in vitro and in vivo via suppressing Wnt\/\u03b2-catenin signaling pathway.","volume":"11","author":"Liu","year":"2018","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.leukres.2024.107593_bib18","first-page":"616","article-title":"[Expression of miR-21 in multiple myeloma and its clinical significance]","volume":"20","author":"Zhang","year":"2012","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.leukres.2024.107593_bib19","first-page":"539","article-title":"The role of miR-29b in cancer: regulation, function, and signaling","volume":"8","author":"Yan","year":"2015","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.leukres.2024.107593_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/10245332.2018.1502961","article-title":"miR-29b inhibits the progression of multiple myeloma through downregulating FOXP1","volume":"24","author":"Wang","year":"2019","journal-title":"Hematology"},{"key":"10.1016\/j.leukres.2024.107593_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020276","article-title":"miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis","volume":"9","author":"Condrat","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.leukres.2024.107593_bib22","first-page":"6094","article-title":"The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma","volume":"15","author":"Zhu","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.leukres.2024.107593_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fgene.2019.00169","article-title":"Blood Circulating miRNAs as cancer biomarkers for diagnosis and surgical treatment response","volume":"10","author":"Filip\u00f3w","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.leukres.2024.107593_bib24","first-page":"882","article-title":"Serum microRNA-125a-5p as a potential biomarker of HCV-associated hepatocellular carcinoma","volume":"18","author":"Oura","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.leukres.2024.107593_bib25","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2020.191229","article-title":"Circulating MicroRNAs in multiple myeloma: a literature review","volume":"66","author":"Tiruneh","year":"2020","journal-title":"Clin. Lab"},{"key":"10.1016\/j.leukres.2024.107593_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clml.2017.05.010","article-title":"Expression of peripheral blood miRNA-720 and miRNA-1246 can be used as a predictor for outcome in multiple myeloma patients","volume":"17","author":"Ren","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.leukres.2024.107593_bib27","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/16078454.2022.2095890","article-title":"The diagnostic and prognostic values of circulating miRNA-1246 in multiple myeloma","volume":"27","author":"Zhao","year":"2022","journal-title":"Hematology"},{"key":"10.1016\/j.leukres.2024.107593_bib28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/15548627.2019.1635380","article-title":"MIR145-3p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4","volume":"16","author":"Wu","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.leukres.2024.107593_bib29","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202009045","article-title":"LNCcation: lncRNA localization and function","volume":"220","author":"Bridges","year":"2021","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.leukres.2024.107593_bib30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood.2022018471","article-title":"RROL lncRNA role in multiple myeloma","volume":"141","author":"Agirre","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107593_bib31","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3727\/096504017X15123872205507","article-title":"Aberrant lncRNA expression in multiple myeloma","volume":"26","author":"Meng","year":"2018","journal-title":"Oncol. Res"},{"key":"10.1016\/j.leukres.2024.107593_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/cac2.12108","article-title":"LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer","volume":"41","author":"Tan","year":"2021","journal-title":"Cancer Commun. (Lond. )"},{"key":"10.1016\/j.leukres.2024.107593_bib33","doi-asserted-by":"crossref","first-page":"101984","DOI":"10.18632\/oncotarget.21957","article-title":"LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR-509-5p to modulate FOXP1 expression","volume":"8","author":"Gu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2024.107593_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106565","article-title":"Long non-coding RNA LINC01003 suppresses the development of multiple myeloma by targeting miR-33a-5p\/PIM1 axis","volume":"106","author":"Wu","year":"2021","journal-title":"Leuk. Res"},{"key":"10.1016\/j.leukres.2024.107593_bib35","article-title":"Long non-coding rnas in multiple myeloma","volume":"5","author":"Butova","year":"2019","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.leukres.2024.107593_bib36","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1002\/jcb.25987","article-title":"LncRNA MALAT-1 elevates HMGB1 to promote autophagy resulting in inhibition of tumor cell apoptosis in multiple myeloma","volume":"118","author":"Gao","year":"2017","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.leukres.2024.107593_bib37","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5517","article-title":"Long non\u2011coding RNAs in multiple myeloma (Review)","volume":"62","author":"Yang","year":"2023","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.leukres.2024.107593_bib38","first-page":"313","article-title":"Research progress of long non-coding RNA in multiple myeloma--review","volume":"32","author":"Cun","year":"2024","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.leukres.2024.107593_bib39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00432-020-03127-8","article-title":"Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p\/SOX13 axis","volume":"146","author":"Liu","year":"2020","journal-title":"J. Cancer Res Clin. Oncol."},{"key":"10.1016\/j.leukres.2024.107593_bib40","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/ejh.13147","article-title":"Bortezomib-based therapy for relapsed\/refractory multiple myeloma in real-world medical practice","volume":"101","author":"Terpos","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.leukres.2024.107593_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.706570","article-title":"LBX2-AS1 as a novel diagnostic biomarker and therapeutic target facilitates multiple myeloma progression by enhancing mRNA stability of LBX2","volume":"8","author":"Jia","year":"2021","journal-title":"Front Mol. Biosci."},{"key":"10.1016\/j.leukres.2024.107593_bib42","first-page":"1085","article-title":"Effect of LINC00174 on the malignant proliferation of multiple myeloma cells and its related mechanism","volume":"31","author":"Wang","year":"2023","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.leukres.2024.107593_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12935-020-1118-1","article-title":"Knockdown of lncRNA SNHG16 suppresses multiple myeloma cell proliferation by sponging miR-342-3p","volume":"20","author":"Yang","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.leukres.2024.107593_bib44","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41388-021-02095-8","article-title":"RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-\u03baB and MAPK signaling pathways","volume":"41","author":"Qu","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2024.107593_bib45","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.21037\/tcr-23-960","article-title":"Novel cuproptosis-related lncRNAs can predict the prognosis of patients with multiple myeloma","volume":"12","author":"Chen","year":"2023","journal-title":"Transl. Cancer Res"},{"key":"10.1016\/j.leukres.2024.107593_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12288-023-01658-x","article-title":"Potential clinical role of LncRNA miR503HG in multiple myeloma and its effect on the proliferation and adhesion of myeloma cells","volume":"40","author":"Yin","year":"2024","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"10.1016\/j.leukres.2024.107593_bib47","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41580-020-0243-y","article-title":"The expanding regulatory mechanisms and cellular functions of circular RNAs","volume":"21","author":"Chen","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.leukres.2024.107593_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102782","article-title":"CircRNA Galntl6 sponges miR-335 to ameliorate stress-induced hypertension through upregulating Lig3 in rostral ventrolateral medulla","volume":"64","author":"Zhang","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.leukres.2024.107593_bib49","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","article-title":"The emerging roles of circRNAs in cancer and oncology","volume":"19","author":"Kristensen","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.leukres.2024.107593_bib50","first-page":"525","article-title":"CircKCNQ5 controls proliferation, migration, invasion, apoptosis, and glycolysis of multiple myeloma cells by modulating miR-335-5p\/BRD4 axis","volume":"38","author":"Li","year":"2023","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.leukres.2024.107593_bib51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s13577-020-00441-8","article-title":"circRNA circ-MYBL2 is a novel tumor suppressor and potential biomarker in multiple myeloma","volume":"34","author":"Yu","year":"2021","journal-title":"Hum. Cell"},{"key":"10.1016\/j.leukres.2024.107593_bib52","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1097\/CAD.0000000000001166","article-title":"Circular RNA circ-CCT3 promotes bortezomib resistance in multiple myeloma via modulating miR-223-3p\/BRD4 axis","volume":"33","author":"Liu","year":"2022","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.leukres.2024.107593_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2021.100381","article-title":"CircRERE confers the resistance of multiple myeloma to bortezomib depending on the regulation of CD47 by exerting the sponge effect on miR-152-3p","volume":"30","author":"Fang","year":"2021","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.leukres.2024.107593_bib54","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13046-019-1071-9","article-title":"CircRNA circ_0000190 inhibits the progression of multiple myeloma through modulating miR-767-5p\/MAPK4 pathway","volume":"38","author":"Feng","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.leukres.2024.107593_bib55","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1080\/16078454.2022.2109554","article-title":"Circ_0003489 facilitates multiple myeloma progression by targeting miR-433-3p\/PBX3 axis","volume":"27","author":"Yan","year":"2022","journal-title":"Hematology"},{"key":"10.1016\/j.leukres.2024.107593_bib56","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.2147\/CMAR.S241089","article-title":"hsa_circRNA_101237: A Novel Diagnostic and Prognostic Biomarker and Potential Therapeutic Target for Multiple Myeloma","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.leukres.2024.107593_bib57","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12935-021-02011-w","article-title":"Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage","volume":"21","author":"Sun","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.leukres.2024.107593_bib58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mce.2003.10.078","article-title":"siRNA technology","volume":"213","author":"Sch\u00fctze","year":"2004","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.leukres.2024.107593_bib59","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12929-023-00981-9","article-title":"Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges","volume":"30","author":"Kang","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.leukres.2024.107593_bib60","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40259-022-00549-3","article-title":"Therapeutic siRNA: state-of-the-art and future perspectives","volume":"36","author":"Friedrich","year":"2022","journal-title":"BioDrugs"},{"key":"10.1016\/j.leukres.2024.107593_bib61","first-page":"477","article-title":"Effect of siRNA-Interfering \u03b2-catenin expression on MDR of human multiple myeloma cell line","volume":"27","author":"Zhang","year":"2019","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.leukres.2024.107593_bib62","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.semcancer.2019.02.001","article-title":"Mechanisms of PTEN loss in cancer: it's all about diversity","volume":"59","author":"\u00c1lvarez-Garcia","year":"2019","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.leukres.2024.107593_bib63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12185-010-0604-y","article-title":"Effect of wild type PTEN gene on proliferation and invasion of multiple myeloma","volume":"92","author":"Wang","year":"2010","journal-title":"Int J. Hematol."},{"key":"10.1016\/j.leukres.2024.107593_bib64","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215711120","article-title":"In vivo bone marrow microenvironment siRNA delivery using lipid-polymer nanoparticles for multiple myeloma therapy","volume":"120","author":"Guimar\u00e3es","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.leukres.2024.107593_bib65","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.tcb.2023.04.002","article-title":"tRNA modifications: insights into their role in human cancers","volume":"33","author":"Wang","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.leukres.2024.107593_bib66","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.7150\/ijbs.80233","article-title":"tRNA modifications and modifying enzymes in disease, the potential therapeutic targets","volume":"19","author":"Cui","year":"2023","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.leukres.2024.107593_bib67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41408-023-00787-w","article-title":"Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma","volume":"13","author":"Kurata","year":"2023","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.leukres.2024.107593_bib68","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0005-2787(73)90384-5","article-title":"The function of Met-tRNAF in the initiation of protein synthesis in mouse myeloma tumors","volume":"312","author":"Jones","year":"1973","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.leukres.2024.107593_bib69","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.2147\/OTT.S302594","article-title":"Expression profiles of tRNA-derived fragments and their potential roles in multiple myeloma","volume":"14","author":"Xu","year":"2021","journal-title":"Oncol. Targets Ther."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624001590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624001590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:37:25Z","timestamp":1778668645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212624001590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":69,"alternative-id":["S0145212624001590"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107593","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roles of noncoding RNAs in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107593"}}